Skip to main content
Top
Published in: Endocrine 3/2019

01-12-2019 | Foreign Body Aspiration | Original Article

Prognosis of patients with differentiated thyroid carcinomas having a preoperative cytological report of indeterminate at low or high risk. A multicenter study

Authors: Pierpaolo Trimboli, Andrea Palermo, Maurilio Deandrea, Arnoldo Piccardo, Alfredo Campennì, Stefano Valabrega, Giorgio Grani, Giuliano Santolamazza, Gianluca Bottoni, Agnese Barnabei, Valeria Ramundo, Rosa Lauretta, Lavinia Monte, Giulia Ferrarazzo, Gaetano Paone, Cecilia Crosetto, Rosaria Maddalena Ruggeri, Sergio Baldari, Alfonsina Chiefari, Sebastiano Vottari, Enrico Giarnieri, Eleonora Perrella, Paolo Limone, Cosimo Durante, Luca Giovanella, Marialuisa Appetecchia, Anna Crescenzi

Published in: Endocrine | Issue 3/2019

Login to get access

Abstract

Background

Italian cytology system for thyroid fine-needle aspiration (FNA) includes indeterminate lesions at low- (Tir 3A) and high-risk (Tir 3B). The present retrospective multicenter study was undertaken to compare the histological type of cancers and disease-free survival in these two groups.

Methods

Eight institutions participated. Thyroid cancer patients diagnosed and followed-up after Tir 3A or Tir 3B were reviewed. Histological diagnosis was adopted as the gold standard. Patients were defined with cancer recurrence or no evidence of disease. Disease-free survival (DFS) was calculated. A non-parametric statistical analysis was used. DFS was estimated by Kaplan–Meier method and Hazard Ratio (HR) defined the slope of curves.

Results

Two hundred and nine patients (median DFS 24 months) were enrolled and a 6.3% of these recurred. Tir 3B group had higher age (p = 0.014), larger cancer size (p = 0.0002), shorter DFS (p = 0.003), higher number of aggressive cancers (p = 0.006), and relapse frequency double than Tir 3A. At survival curves analysis, Tir 3B group had HR of 2.37 with respect to Tir 3A. At Cox’s proportional hazard regression analysis histology was the only significant predictor of relapse.

Conclusions

While patients with thyroid FNA of Tir 3B should be addressed to surgery due to high likelihood of more aggressive cancer, a diagnostic surgery could be avoided in patients with Tir 3A if concurrent unsuspicious clinical features are found.
Literature
1.
go back to reference H. Gharib, E. Papini, R. Paschke et al. American association of clinical endocrinologists, associazione medici endocrinologi, and european thyroid association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr. Pract. 16(Suppl 1), 1–43 (2010)CrossRef H. Gharib, E. Papini, R. Paschke et al. American association of clinical endocrinologists, associazione medici endocrinologi, and european thyroid association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr. Pract. 16(Suppl 1), 1–43 (2010)CrossRef
2.
go back to reference B.R. Haugen, E.K. Alexander, K.C. Bible et al. American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the american thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 2016(26), 1–133 (2015) B.R. Haugen, E.K. Alexander, K.C. Bible et al. American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the american thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 2016(26), 1–133 (2015)
3.
go back to reference Z.W. Baloch, S. Fleisher, V.A. LiVolsi, P.K. Gupta, Diagnosis of “follicular neoplasm”: a gray zone in thyroid fine-needle aspiration cytology. Diagn. Cytopathol. 26, 41–44 (2002)CrossRef Z.W. Baloch, S. Fleisher, V.A. LiVolsi, P.K. Gupta, Diagnosis of “follicular neoplasm”: a gray zone in thyroid fine-needle aspiration cytology. Diagn. Cytopathol. 26, 41–44 (2002)CrossRef
4.
go back to reference E.K. Alexander, G.C. Kennedy, Z.W. Baloch et al. Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. N. Engl. J. Med. 367, 705–715 (2012)CrossRef E.K. Alexander, G.C. Kennedy, Z.W. Baloch et al. Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. N. Engl. J. Med. 367, 705–715 (2012)CrossRef
5.
go back to reference P. Perros, K. Boelaert, S. Colley et al. Guidelines for the management of thyroid cancer. Clin. Endocrinol. (Oxf.). 81(Suppl 1), 1–122 (2014)CrossRef P. Perros, K. Boelaert, S. Colley et al. Guidelines for the management of thyroid cancer. Clin. Endocrinol. (Oxf.). 81(Suppl 1), 1–122 (2014)CrossRef
6.
go back to reference E.S. Cibas, S.Z. Ali, The Bethesda system for reporting thyroid cytopathology. Thyroid 19, 1159–1165 (2009)CrossRef E.S. Cibas, S.Z. Ali, The Bethesda system for reporting thyroid cytopathology. Thyroid 19, 1159–1165 (2009)CrossRef
7.
go back to reference F. Nardi, F. Basolo, A. Crescenzi et al. Italian consensus for the classification and reporting of thyroid cytology. J. Endocrinol. Invest. 37, 593–599 (2014)CrossRef F. Nardi, F. Basolo, A. Crescenzi et al. Italian consensus for the classification and reporting of thyroid cytology. J. Endocrinol. Invest. 37, 593–599 (2014)CrossRef
8.
go back to reference P. Trimboli, A. Crescenzi, L. Giovanella, Performance of Italian consensus for the classification and reporting of thyroid cytology (ICCRTC) in discriminating indeterminate lesions at low and high risk of malignancy. A systematic review and meta-analysis. Endocrine 60, 31–35 (2018)CrossRef P. Trimboli, A. Crescenzi, L. Giovanella, Performance of Italian consensus for the classification and reporting of thyroid cytology (ICCRTC) in discriminating indeterminate lesions at low and high risk of malignancy. A systematic review and meta-analysis. Endocrine 60, 31–35 (2018)CrossRef
9.
go back to reference P. Trimboli, A. Crescenzi, M. Castellana, F. Giorgino, L. Giovanella, M. Bongiovanni, Italian consensus for the classification and reporting of thyroid cytology: the risk of malignancy between indeterminate lesions at low or high risk. A systematic review and meta-analysis. Endocrine 63(3), 430–438 (2018)CrossRef P. Trimboli, A. Crescenzi, M. Castellana, F. Giorgino, L. Giovanella, M. Bongiovanni, Italian consensus for the classification and reporting of thyroid cytology: the risk of malignancy between indeterminate lesions at low or high risk. A systematic review and meta-analysis. Endocrine 63(3), 430–438 (2018)CrossRef
10.
go back to reference G. Grani, L. Lamartina, C. Durante, S. Filetti, D.S. Cooper, Follicular thyroid cancer and Hürthle cell carcinoma: challenges in diagnosis, treatment, and clinical management. Lancet Diabetes Endocrinol. 6, 500–514 (2018)CrossRef G. Grani, L. Lamartina, C. Durante, S. Filetti, D.S. Cooper, Follicular thyroid cancer and Hürthle cell carcinoma: challenges in diagnosis, treatment, and clinical management. Lancet Diabetes Endocrinol. 6, 500–514 (2018)CrossRef
11.
go back to reference WHO Classification of Tumours of Endocrine Organs, 4th edn., vol. 10, ed. by R.V. Lloyd, R.Y. Osamura, G. Klöppel, J. Rosai (International Agency for Research on Cancer, Lyon, 2017) WHO Classification of Tumours of Endocrine Organs, 4th edn., vol. 10, ed. by R.V. Lloyd, R.Y. Osamura, G. Klöppel, J. Rosai (International Agency for Research on Cancer, Lyon, 2017)
12.
go back to reference I.J. Nixon, L.Y. Wang, J.C. Migliacci et al. An international multi-institutional validation of age 55 Years as a cutoff for risk stratification in the AJCC/UICC staging system for well-differentiated thyroid cancer. Thyroid 26, 373–380 (2016)CrossRef I.J. Nixon, L.Y. Wang, J.C. Migliacci et al. An international multi-institutional validation of age 55 Years as a cutoff for risk stratification in the AJCC/UICC staging system for well-differentiated thyroid cancer. Thyroid 26, 373–380 (2016)CrossRef
13.
go back to reference P. Straccia, E.D. Rossi, T. Bizzarro et al. A meta-analytic review of the Bethesda system for reporting thyroid cytopathology: has the rate of malignancy in indeterminate lesions been underestimated? Cancer Cytopathol. 123, 713–722 (2015)CrossRef P. Straccia, E.D. Rossi, T. Bizzarro et al. A meta-analytic review of the Bethesda system for reporting thyroid cytopathology: has the rate of malignancy in indeterminate lesions been underestimated? Cancer Cytopathol. 123, 713–722 (2015)CrossRef
14.
go back to reference M. Bongiovanni, A. Spitale, W.C. Faquin, L. Mazzucchelli, Z.W. Baloch, The Bethesda system for reporting thyroid cytopathology: a meta-analysis. Acta Cytol. 56, 333–339 (2012)CrossRef M. Bongiovanni, A. Spitale, W.C. Faquin, L. Mazzucchelli, Z.W. Baloch, The Bethesda system for reporting thyroid cytopathology: a meta-analysis. Acta Cytol. 56, 333–339 (2012)CrossRef
15.
go back to reference S.H. Ahn, S.D. Kim, W.J. Jeong, Comparison of risk of malignancy in a subgroup with atypia of undetermined significance/follicular lesion of undetermined significance: a meta-analysis. Head. Neck. 39, 1699–1710 (2017)CrossRef S.H. Ahn, S.D. Kim, W.J. Jeong, Comparison of risk of malignancy in a subgroup with atypia of undetermined significance/follicular lesion of undetermined significance: a meta-analysis. Head. Neck. 39, 1699–1710 (2017)CrossRef
16.
go back to reference P. Valderrabano, L. Khazai, Z.J. Thompson, S.C. Sharpe, V.D. Tarasova, K.J. Otto, J.E. Hallanger-Johnson, J.T. Wadsworth, B.M. Wenig, C.H. Chung, B.A. Centeno, B. McIver, Cancer risk associated with nuclear atypia in cytologically indeterminate thyroid nodules: a systematic review and meta-analysis. Thyroid 28, 210–219 (2018)CrossRef P. Valderrabano, L. Khazai, Z.J. Thompson, S.C. Sharpe, V.D. Tarasova, K.J. Otto, J.E. Hallanger-Johnson, J.T. Wadsworth, B.M. Wenig, C.H. Chung, B.A. Centeno, B. McIver, Cancer risk associated with nuclear atypia in cytologically indeterminate thyroid nodules: a systematic review and meta-analysis. Thyroid 28, 210–219 (2018)CrossRef
17.
go back to reference M. Bongiovanni, L. Giovanella, F. Romanelli, P. Trimboli, Cytological diagnoses associated with non-invasive follicular thyroid neoplasms with papillary-like nuclear features, (NIFTP) according to the Bethesda System for Reporting Thyroid Cytopathology: a systematic review and meta-analysis. Thyroid 29, 222–228 (2018) M. Bongiovanni, L. Giovanella, F. Romanelli, P. Trimboli, Cytological diagnoses associated with non-invasive follicular thyroid neoplasms with papillary-like nuclear features, (NIFTP) according to the Bethesda System for Reporting Thyroid Cytopathology: a systematic review and meta-analysis. Thyroid 29, 222–228 (2018)
18.
go back to reference T. Rago, M. Scutari, F. Latrofa, V. Loiacono, P. Piaggi, I. Marchetti, R. Romani, F. Basolo, P. Miccoli, M. Tonacchera et al. The large majority of 1520 patients with indeterminate thyroid nodule at cytology have a favorable outcome, and a clinical risk score has a high negative predictive value for a more cumbersome cancer disease. J. Clin. Endocrinol. Metab. 99, 3700–3707 (2014)CrossRef T. Rago, M. Scutari, F. Latrofa, V. Loiacono, P. Piaggi, I. Marchetti, R. Romani, F. Basolo, P. Miccoli, M. Tonacchera et al. The large majority of 1520 patients with indeterminate thyroid nodule at cytology have a favorable outcome, and a clinical risk score has a high negative predictive value for a more cumbersome cancer disease. J. Clin. Endocrinol. Metab. 99, 3700–3707 (2014)CrossRef
19.
go back to reference P. Trimboli, M. Bongiovanni, F. Rossi, L. Guidobaldi, A. Crescenzi, L. Ceriani, G. Nigri, S. Valabrega, F. Romanelli, L. Giovanella, Differentiated thyroid cancer patients with a previous indeterminate (Thy 3) cytology have a better prognosis than those with suspicious or malignant FNAC reports. Endocrine 49, 191–195 (2015)CrossRef P. Trimboli, M. Bongiovanni, F. Rossi, L. Guidobaldi, A. Crescenzi, L. Ceriani, G. Nigri, S. Valabrega, F. Romanelli, L. Giovanella, Differentiated thyroid cancer patients with a previous indeterminate (Thy 3) cytology have a better prognosis than those with suspicious or malignant FNAC reports. Endocrine 49, 191–195 (2015)CrossRef
20.
go back to reference M. Deandrea, F. Ragazzoni, M. Motta, B. Torchio, A. Mormile, F. Garino, G. Magliona, E. Gamarra, M.J. Ramunni, R. Garberoglio, P.P. Limone, Diagnostic value of a cytomorphological subclassification of follicular patterned thyroid lesions: a study of 927 consecutive cases with histological correlation. Thyroid 20, 1077–1083 (2010)CrossRef M. Deandrea, F. Ragazzoni, M. Motta, B. Torchio, A. Mormile, F. Garino, G. Magliona, E. Gamarra, M.J. Ramunni, R. Garberoglio, P.P. Limone, Diagnostic value of a cytomorphological subclassification of follicular patterned thyroid lesions: a study of 927 consecutive cases with histological correlation. Thyroid 20, 1077–1083 (2010)CrossRef
21.
go back to reference S. Sciacchitano, L. Lavra, A. Ulivieri, F. Magi, T. Porcelli, S. Amendola, G.P. De Francesco, C. Bellotti, M.C. Trovato, L.B. Salehi, et al. Combined clinical and ultrasound follow-up assists in malignancy detection in Galectin-3 negative Thy-3 thyroid nodules. Endocrine 54, 139–147 (2016)CrossRef S. Sciacchitano, L. Lavra, A. Ulivieri, F. Magi, T. Porcelli, S. Amendola, G.P. De Francesco, C. Bellotti, M.C. Trovato, L.B. Salehi, et al. Combined clinical and ultrasound follow-up assists in malignancy detection in Galectin-3 negative Thy-3 thyroid nodules. Endocrine 54, 139–147 (2016)CrossRef
Metadata
Title
Prognosis of patients with differentiated thyroid carcinomas having a preoperative cytological report of indeterminate at low or high risk. A multicenter study
Authors
Pierpaolo Trimboli
Andrea Palermo
Maurilio Deandrea
Arnoldo Piccardo
Alfredo Campennì
Stefano Valabrega
Giorgio Grani
Giuliano Santolamazza
Gianluca Bottoni
Agnese Barnabei
Valeria Ramundo
Rosa Lauretta
Lavinia Monte
Giulia Ferrarazzo
Gaetano Paone
Cecilia Crosetto
Rosaria Maddalena Ruggeri
Sergio Baldari
Alfonsina Chiefari
Sebastiano Vottari
Enrico Giarnieri
Eleonora Perrella
Paolo Limone
Cosimo Durante
Luca Giovanella
Marialuisa Appetecchia
Anna Crescenzi
Publication date
01-12-2019
Publisher
Springer US
Published in
Endocrine / Issue 3/2019
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-019-02013-9

Other articles of this Issue 3/2019

Endocrine 3/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.